Algernon Pharmaceuticals Inc. (CSE: AGN)

Algernon Pharmaceuticals Balance Sheet

Financials in millions CAD. Fiscal year is September - August.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	May 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021	Aug 31, 2020	Aug 31, 2019
Cash & Equivalents	0.61	0.13	1.41	2.41	6.12	0.21
Cash & Short-Term Investments	0.61	0.13	1.41	2.41	6.12	0.21
Cash Growth	40.37%	-91.12%	-41.58%	-60.61%	2845.65%	-83.39%
Other Receivables	0.01	0.1	0.67	2.29	1.23	0.04
Receivables	0.01	0.1	0.67	2.29	1.23	0.04
Prepaid Expenses	0.07	0.12	0.75	0.2	0.39	0.03
Total Current Assets	0.69	0.34	2.83	4.91	7.74	0.28
Other Intangible Assets	3.18	3.8	5.26	5.17	5.03	5
Long-Term Deferred Charges	-	-	-	-	-	0
Other Long-Term Assets	0.03	0.06	0.06	0.06	0.06	0.06
Total Assets	3.89	4.19	8.14	10.14	12.82	5.34
Accounts Payable	1.76	2.7	2.24	1.02	0.61	0.37
Accrued Expenses	0.17	0.02	0.27	0	-	0
Total Current Liabilities	1.93	2.72	2.52	1.02	0.61	0.37
Total Liabilities	1.93	2.72	2.52	1.02	0.61	0.37
Common Stock	29.14	28.15	27.12	25.85	21.34	12.59
Retained Earnings	-30.44	-30.79	-25.19	-23.55	-17.46	-10.27
Comprensive Income & Other	3.26	4.12	3.7	6.81	8.34	2.65
Shareholders' Equity	1.96	1.47	5.62	9.12	12.22	4.97
Total Liabilities & Equity	3.89	4.19	8.14	10.14	12.82	5.34
Net Cash (Debt)	0.61	0.13	1.41	2.41	6.12	0.21
Net Cash Growth	40.37%	-91.12%	-41.58%	-60.61%	2845.65%	-83.39%
Net Cash Per Share	0.03	0.01	0.20	0.39	1.74	0.12
Filing Date Shares Outstanding	21.94	19.51	9.54	6.7	5.7	2.87
Total Common Shares Outstanding	21.94	15.78	9.43	6.7	5.53	1.89
Working Capital	-1.24	-2.38	0.31	3.89	7.13	-0.09
Book Value Per Share	0.09	0.09	0.60	1.36	2.21	2.63
Tangible Book Value	-1.22	-2.32	0.37	3.94	7.19	-0.03
Tangible Book Value Per Share	-0.06	-0.15	0.04	0.59	1.30	-0.01

Source: S&P Capital IQ. Standard template. Financial Sources.